NewsBenzingaLeerink Partners Maintains Outperform on Twist Bioscience, Lowers Price Target to $175 Leerink Partners Maintains Outperform on Twist Bioscience, Lowers Price Target to $175 Benzinga 2026.11.13 20:16 (GMT+0) Open on Benzinga Other news Meta Internally Tests Prediction Market App 'Takes' Microsoft Says Infrastructure Stabilizes As Queued Messages Drain And Traffic Rebalances, With No ETA For Full Recovery JP Morgan Maintains Overweight on Sea, Lowers Price Target to $132 JP Morgan Maintains Overweight on Lithium Americas, Lowers Price Target to $5 JP Morgan Maintains Overweight on Cellebrite DI, Lowers Price Target to $15 JP Morgan Maintains Overweight on Brookfield, Lowers Price Target to $64
Microsoft Says Infrastructure Stabilizes As Queued Messages Drain And Traffic Rebalances, With No ETA For Full Recovery
